Neurophysiological Assessment of Cognitive Dysfunction in Patients with Multiple Sclerosis

1. Hoffmann S, Tittgemeyer M, von Cramon DY.(2007) Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007; 20(3): 275-80.10.1097/WCO.0b013e32810c8e8717495620Open DOISearch in Google Scholar

2. Amato MP, Zipoli V, Portaccio E.(2006) Multiple sclerosis-related cognitive changes: a review of crosssectional and longitudinal studies. J Neurol Sci 2006; 245(1-2): 41-6.10.1016/j.jns.2005.08.01916643953Search in Google Scholar

3. Barker-Collo SL.(2005) Within session practice effects on the PASAT and clients with multiple sclerosis. Arch Neuropsychol Clin. 2005; 20(2): 145-52.10.1016/j.acn.2004.03.00715708724Search in Google Scholar

4. Ivica N, Titlic M, Pavelin S. (2013) P300 wave changes in patients with multiple sclerosis. Acta Med Inform. 2013; 21(3): 205-7.10.5455/aim.2013.21.205-207380449924167393Open DOISearch in Google Scholar

5. Piras MR, Sognano I, Cani ED at all. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological and neurophysiological findings. J Neurol, Neurosurg, Psychiatry 2003;74:878-885.10.1136/jnnp.74.7.878173856412810771Open DOISearch in Google Scholar

6. Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Bramham J, O’Brien M, Reilly RB, Hutchinson M, Tubridy N. A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls. Clin Neurophysiol 2010;121(9):1420-6.10.1016/j.clinph.2010.03.01920381418Search in Google Scholar

7. Kiiski H, Reilly RB, LonerganR at all.(2011) Change in PASAT correlates with in P3 ERP amplitude over a 12-month period in multiple sclerosis patients. Journal of the Neurological Science 2011;305(1):42-52.Search in Google Scholar

8. Sailer M, Heinze HJ, Tendolkar I, Decker U, KreyeO, v Rolbicki U, Münte TF (2001). Influence of cerebral lesion volume and lesion distribution on eventrelated brain potentials in multiple sclerosis. J Neurol 2001;248(12):1049-55.Search in Google Scholar

9. Mathias Sundgren, Vadim V, Nikulin, Liselotte Maurex, ÅkeWahlin, Fredrik Piehl, Tom Brismar. (2015) P300 amplitude and response speed relate to preserved cognitive function in relapsing–remitting multiple sclerosis. Clinical Neurophysiology 2015;126(4):689-697.10.1016/j.clinph.2014.07.02425200462Search in Google Scholar

10. Filippi, M, Rocca, MA, Benedict RHB, DeLuca J, Geurts JG, Rombouts, SARB, Ron, M, andComi G. (2010) The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75(23): 2121–2128.10.1212/WNL.0b013e318200d768338542321135387Search in Google Scholar

11. Mainero C, Caramia F, Pozzilli C, Pisani A, Pestalozza I, Borriello G et al. (2004) fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 2004;21(3):858-67.10.1016/j.neuroimage.2003.10.00415006652Open DOISearch in Google Scholar

12. Roy S, Benedict RH , Drake AS, Weinstock-Guttman B.(2016) Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis. CNS Drug 2016; 30(3): 209-225.10.1007/s40263-016-0319-626884145Search in Google Scholar

13. Filipovic S, Drulovic J, Stojisavljevic N, Levic Z.(1997) The effects of high-dose intravenous methylprednisolone on event-related potentials in patients with multiple sclerosis. J of Neurological Science 1997;152:147-153.10.1016/S0022-510X(97)00159-7Search in Google Scholar

14. Baykara E, Ruf CA, Fioravanti C, Käthner I, Simon N, Kleih SC, Kübler A, Halder.(2016) Effects of training and motivation on auditory P300 brain-computer interface performance. Clin Neurophysiol 2016; 127(1):379-87.10.1016/j.clinph.2015.04.05426051753Search in Google Scholar